Authors
Loading...
Assessment shows enhanced agonist potency and efficacy in A3 adenosine receptors, indicating novel bitopic molecular probes.
Kurma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: